- $104.24m
- $82.10m
- $54.90m
Brief: Joint Q3 EPS USD -0.05
Brief: Joint Q2 EPS USD -0.01
Brief: Joint Corp - JP Morgan Chase Waived, On A One-Time Only Basis, Default That Occurred Under Credit Agreement
Brief: Joint Corp Intends To Restate Previously Issued Audited Financial Statements As Of And For Year Ending 2022 Contained In Annual Report On Form 10-K
Brief: The Joint Corp. Announces Receipt Of Delinquency Notification Letter From Nasdaq
Brief: Joint posts Q2 revenue USD 120.1 million
Joint Corp expected to post earnings of 2 cents a share - Earnings Preview
Joint Corp reports results for the quarter ended in March - Earnings Summary
Brief: Joint sees FY revenue USD 123-128 million
Joint Corp expected to post a loss of 1 cent a share - Earnings Preview
Joint Corp reports results for the quarter ended in December - Earnings Summary
Brief: Joint reports Q4 revenue USD 27.8 million
Brief: The Joint Corp Reports Fourth Quarter And Year-End 2022 Financial Results
Joint Corp expected to post earnings of 8 cents a share - Earnings Preview
Joint Corp rises on 'positive' operating metrics for FY 2022
Brief: The Joint Corp Reports 2022 Operating Metrics
Brief: The Joint Chiropractic Expands To Alaska, Signs Franchise Agreement For Three Clinics
Joint Corp reports results for the quarter ended in September - Earnings Summary
Joint Corp expected to post earnings of 6cents a share - Earnings Preview